CD4 and myeloid sarcoma: Nevertheless, a greater proportion of CD4+ Th1 and Th1-like responding cells in MS-OCR patients co-expressed three dynamic markers compared to HCs (Figure 4j–k, and Figure 4—figure supplement 1e).